ArticleJournal of racial and ethnic health disparities2026
Understanding System-Level Experiences Impacting Black Americans' Adherence to Antihypertensive Medication.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Black Americans have higher rates of antihypertensive medication nonadherence, leading to increased morbidity and mortality. The impact of system-level experiences on medication adherence (MA) has so far been understudied. We sought to understand patients' perceptions of system-level experiences influencing antihypertensive MA. Using a qualitative descriptive design, we conducted semi-structured interviews via Zoom. Transcripts were reviewed and coded, with spot checking of themes and coding by a second team member. A community advisory group performed member checking as a credibility audit. Fifteen participants were enrolled. We identified four main themes: social and economic barriers, social and economic facilitators, health system-level barriers, and health system-level facilitators. Subthemes highlighted logistical challenges and the complexities of system-level impacts on antihypertensive MA. Social and economic and health system-level facilitators should be considered when designing future interventions to promote antihypertensive MA and when augmenting existing policy and healthcare delivery structures.
Indexed as
Identifiers
40555900What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.